Oncology Booming But Cost Outlook Grim, IMS Says
This article was originally published in PharmAsia News
Executive Summary
The cost of oncology therapeutics and supportive care drugs grew 11.5% to $107bn in 2015 at constant exchange rates and is expected to reach $150bn globally in 2020, according to a new report.